Document:

Exhibit
10.1

 

____,
2022

Bombax Healthcare Acquisition Corporation

221 Henderson Road

#01-05 Henderson Road

Singapore 159557

 

JonesTrading
Institutional Services LLC

757 3rd Avenue, 23rd floor

New
York, NY 10017

 

Re: Initial
Public Offering

 

Ladies
and Gentlemen:

 

This
letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”)
entered into by and between Bombax Healthcare Acquisition Corporation, a Cayman Islands company (the “Company”),
and JonesTrading Institutional Services LLC, as Representative (the “Representative”) of the several underwriters
named on Schedule A thereto (the “Underwriters”), relating to an underwritten initial public offering (the
“IPO”) of the Company’s units (the “Units”), each comprised of one Class A
ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), one-half (1/2) of one redeemable
warrant, each whole warrant entitling its holder to purchase one Class A Ordinary Share at an exercise price of $11.50 per full share
(the “Warrants”). Certain capitalized terms used herein are defined in paragraph 14 hereof.

 

In
order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the IPO, and in recognition
of the benefit that such IPO will confer upon the undersigned as a shareholder of the Company, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the undersigned hereby agrees with the Company as follows:

 

1. If
the Company solicits approval of its shareholders of a Business Combination, the undersigned will vote all Ordinary Shares beneficially
owned by him, her or it, whether acquired before, in or after the IPO, in favor of such Business Combination.

 

2. (a)
Unless the Company’s shareholders are previously given the option to redeem their shares in connection with amending applicable
documents to extend the time that the Company has to complete a Business Combination and that the Company fails to consummate a Business
Combination within 12 months (or up to 24 months if the Company chooses to extend such period) from the closing of the Company’s
IPO from the closing of the Company’s IPO, the undersigned shall take all reasonable steps to (i) cause the Trust Fund to be liquidated
and distributed to the holders of the IPO Shares and (ii) cause the Company to liquidate as soon as reasonably practicable.

 

(b) The
undersigned hereby waives any and all right, title, interest or claim of any kind in or to any distribution of the Trust Fund and any
remaining net assets of the Company as a result of such liquidation with respect to his, her or its Insider Shares [including any shares
underlying the Private Placement Warrants]1 (“Claim”) and hereby waives any Claim the undersigned
may have in the future as a result of, or arising out of, any contracts or agreements with the Company and will not seek recourse against
the Trust Fund for any reason whatsoever. [The undersigned acknowledges and agrees that there will be no distribution from the Trust
Fund with respect to any Warrants or Rights underlying the Private Placement Warrants, all of which will terminate on the Company’s
liquidation.]2

 

[(c) In
the event of the liquidation of the Trust Fund, the undersigned agrees to indemnify and hold harmless the Company against any and all
loss, liability, claims, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably
incurred in investigating, preparing or defending against any litigation, whether pending or threatened, or any claim whatsoever) which
the Company may become subject as a result of any claim by any vendor or other person who is owed money by the Company for services rendered
or products sold or contracted for, but only to the extent necessary to ensure that such loss, liability, claim, damage or expense does
not reduce the amount of funds in the Trust Fund; provided, that such indemnity shall not apply if such vendor or other person has executed
an agreement waiving any claims against the Trust Fund.]3

 

 

 

 

 

		1	NTD: Only include for Bombax Capital Partners Limited and Be Expert Limited.
		2	NTD:
Only include for Bombax Capital Partners Limited and Be Expert Limited.

		3	NTD:
Only include for Bombax Capital Partners Limited and Be Expert Limited.

 

     

     

    

 

3.
[In the event that the Company does not consummate a Business Combination and must liquidate and its remaining net assets are insufficient
to complete such liquidation, the undersigned agrees to advance such funds necessary to complete such liquidation and agrees not to seek
recourse for such expenses.]4

 

4. The
undersigned will escrow all of his, her or its Insider Shares pursuant to the terms of a Stock Escrow Agreement, which the Company will
enter into with the undersigned and an escrow agent acceptable to the Company.

 

5. [The
undersigned agrees that until the Company consummates a Business Combination, the undersigned’s Private Placement Warrants will
be subject to the transfer restrictions described in the Subscription Agreement relating to the undersigned’s Private Placement
Warrants.]5

 

6. In
order to minimize potential conflicts of interest which may arise from multiple affiliations, the undersigned agrees to present to the
Company for its consideration, prior to presentation to any other person or entity, any suitable opportunity to acquire a target business,
until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company, subject to any pre-existing
fiduciary and contractual obligations the undersigned might have.

 

7. The
undersigned acknowledges and agrees that prior to entering into a Business Combination with a target business that is affiliated with
any Insiders of the Company or their affiliates, including any company that is a portfolio company of, or otherwise affiliated with,
or has received financial investment from, an entity with which any Insider or their affiliates is affiliated, such transaction must
be approved by a majority of the Company’s disinterested independent directors and the Company must obtain an opinion from an independent
investment banking firm or another independent entity that commonly renders valuation opinions that such Business Combination is fair
to the Company’s unaffiliated shareholders from a financial point of view.

 

8. Neither
the undersigned, any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to receive and will
not accept any compensation or other cash payment prior to, or for services rendered in connection with, the consummation of the Business
Combination; provided that the Company shall be allowed to repay working capital loans made by the undersigned to the Company
in cash upon consummation of the Business Combination. Notwithstanding the foregoing, the undersigned and any affiliate of the undersigned
shall be entitled to reimbursement from the Company for their out-of-pocket expenses incurred in connection with identifying, investigating
and consummating a Business Combination.

 

9. Neither
the undersigned, any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to receive or accept
a finder’s fee or any other compensation in the event the undersigned, any member of the family of the undersigned or any affiliate
of the undersigned originates a Business Combination.

 

 

 

 

 

		4	NTD:
Only include for Bombax Capital Partners Limited and Be Expert Limited.

		5	NTD:
Only include for Bombax Capital Partners Limited and Be Expert Limited.

 

    2

     

    

 

10.
[The undersigned agrees to be a director/officer of the Company until the earlier of the consummation by the Company of a Business Combination
or the liquidation of the Company. The undersigned’s biographical information previously furnished to the Company and the Representative
is true and accurate in all material respects, does not omit any material information with respect to the undersigned’s biography
and contains all of the information required to be disclosed pursuant to Item 401 of Regulation S-K, promulgated under the Securities
Act of 1933.]6 The undersigned’s FINRA Questionnaire previously furnished to the Company and the Representative is
true and accurate in all material respects. The undersigned represents and warrants that:

 

		(a)	He,
                                            she or it has never had a petition under the federal bankruptcy laws or any state insolvency
                                            law been filed by or against (i) him, her or it, or any partnership in which he or she was
                                            a general partner at or within two years before the time of filing; or (ii) any corporation
                                            or business association of which he or she was an executive officer at or within two years
                                            before the time of such filing;

 

		(b)	He,
                                            she or it has never had a receiver, fiscal agent or similar officer been appointed by a court
                                            for his business or property, or any such partnership;

 

		(c)	He,
                                            she or it has never been convicted of fraud in a civil or criminal proceeding;

 

		(d)	He,
                                            she or it has never been convicted in a criminal proceeding or named the subject of a pending
                                            criminal proceeding (excluding traffic violations and minor offenses);

 

		(e)	He,
                                            she or it has never been the subject of any order, judgment or decree, not subsequently reversed,
                                            suspended or vacated, of any court of competent jurisdiction, permanently or temporarily
                                            enjoining or otherwise limiting him, her or it from (i) acting as a futures commission merchant,
                                            introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage
                                            transaction merchant, any other person regulated by the Commodity Futures Trading Commission
                                            (“CFTC”) or an associated person of any of the foregoing, or as an investment
                                            adviser, underwriter, broker or dealer in securities, or as an affiliated person, director
                                            or employee of any investment company, bank, savings and loan association or insurance company,
                                            or from engaging in or continuing any conduct or practice in connection with any such activity;
                                            or (ii) engaging in any type of business practice; or (iii) engaging in any activity
                                            in connection with the purchase or sale of any security or commodity or in connection with
                                            any violation of federal or state securities or federal commodities laws;

 

		(f)	He,
                                            she, or it has never been the subject of any order, judgment or decree, not subsequently
                                            reversed, suspended or vacated, of any federal or state authority barring, suspending or
                                            otherwise limiting for more than 60 days his, her or its right to engage in any activity
                                            described in 10(e)(i) above, or to be associated with persons engaged in any such activity;

 

 

 

 

 

		6	NTD: Only remove for Bombax Capital Partners Limited and Be Expert Limited.

 

    3

     

    

 

		(g)	He,
                                            she, or it has never been found by a court of competent jurisdiction in a civil action or
                                            by the SEC to have violated any federal or state securities law, where the judgment in such
                                            civil action or finding by the SEC has not been subsequently reversed, suspended or vacated;

 

		(h)	He,
                                            she, or it has never been found by a court of competent jurisdiction in a civil action or
                                            by the CFTC to have violated any federal commodities law, where the judgment in such civil
                                            action or finding by the CFTC has not been subsequently reversed, suspended or vacated;

 

		(i)	He,
                                            she, or it has never been the subject of, or a party to, any Federal, State or foreign judicial
                                            or administrative order, judgment, decree or finding, not subsequently reversed, suspended
                                            or vacated, relating to an alleged violation of (i) any Federal, State or foreign securities
                                            or commodities law or regulation, (ii) any law or regulation respecting financial institutions
                                            or insurance companies including, but not limited to, a temporary or permanent injunction,
                                            order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and
                                            desist order, or removal or prohibition order or (iii) any law or regulation prohibiting
                                            mail or wire fraud or fraud in connection with any business entity;

 

		(j)	He,
                                            she or it has never been the subject of, or party to, any sanction or order, not subsequently
                                            reversed, suspended or vacated, or any self-regulatory organization, any registered entity,
                                            or any equivalent exchange, association, entity or organization that has disciplinary authority
                                            over its members or persons associated with a member;

 

		(k)	He,
                                            she or it has never been convicted of any felony or misdemeanor: (i) in connection with the
                                            purchase or sale of any security; (ii) involving the making of any false filing with the
                                            SEC; or (iii) arising out of the conduct of the business of an underwriter, broker, dealer,
                                            municipal securities dealer, investment advisor or paid solicitor of purchasers of securities;

 

		(l)	He,
                                            she or it was never subject to a final order of a state or foreign securities commission
                                            (or an agency of officer of a state performing like functions); a state or foreign authority
                                            that supervises or examines banks, savings associations, or credit unions; a state or foreign
                                            insurance commission (or an agency or officer of a state performing like functions); an appropriate
                                            federal or foreign banking agency; the CFTC; or the National Credit Union Administration
                                            that is based on a violation of any law or regulation that prohibits fraudulent, manipulative,
                                            or deceptive conduct;

 

		(m)	He,
                                            she or it has never been subject to any order, judgment or decree of any court of competent
                                            jurisdiction, that, at the time of the sale of the Units, restrained or enjoined him, her
                                            or it from engaging or continuing to engage in any conduct or practice: (i) in connection
                                            with the purchase or sale of any security; (ii) involving the making of any false filing
                                            with the SEC or any foreign regulatory agency with similar functions; or (iii) arising out
                                            of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer,
                                            investment adviser or paid solicitor of purchasers of securities;

 

		(n)	He,
                                            she or it has never been subject to any order of the SEC or any foreign regulatory agency
                                            with similar functions that orders him, her or it to cease and desist from committing or
                                            causing a future violation of: (i) any scienter-based anti-fraud provision of the federal
                                            securities laws, including, but not limited to, Section 17(a)(1) of the Securities Act, Section
                                            10(b) of the Exchange Act and Rule 10b-5 thereunder, Section 15(c) and Section 206(1) of
                                            the Advisers Act or any other rule or regulation thereunder; or (ii) Section 5 of the Securities
                                            Act;

 

    4

     

    

 

		(o)	He,
                                            she or it has never filed (as a registrant or issuer), or been named as an underwriter in
                                            any registration statement or Regulation A offering statement filed with the SEC that was
                                            the subject of a refusal order, stop order, or order suspending the Regulation A exemption,
                                            or is, currently, the subject of an investigation or proceeding to determine whether a stop
                                            order or suspension order should be issued;

 

		(p)	He,
                                            she or it has never been subject to a United States Postal Service false representation order,
                                            or is currently subject to a temporary restraining order or preliminary injunction with respect
                                            to conduct alleged by the United States Postal Service to constitute a scheme or device for
                                            obtaining money or property through the mail by means of false representations;

 

		(q)	He,
                                            she or it is not subject to a final order of a state securities commission (or an agency
                                            of officer of a state performing like functions); a state authority that supervises or examines
                                            banks, savings associations, or credit unions; a state insurance commission (or an agency
                                            or officer of a state performing like functions); an appropriate federal banking agency;
                                            the CFTC; or the National Credit Union Administration that bars the undersigned from: (i)
                                            association with an entity regulated by such commission, authority, agency or officer; (ii)
                                            engaging in the business of securities, insurance or banking; or (iii) engaging in savings
                                            association or credit union activities;

 

		(r)	He,
                                            she or it is not subject to an order of the SEC entered pursuant to section 15(b) or 15B(c)
                                            of the Securities Exchange Act of 1934 (the “Exchange Act”) or section 203(e)
                                            or 203(f) of the Investment Advisers Act of 1940 (the “Advisers Act”) that: (i)
                                            suspends or revokes the undersigned’s registration as a broker, dealer, municipal securities
                                            dealer or investment adviser; (ii) places limitations on the activities, functions or operations
                                            of, or imposes civil money penalties on, such person; or (iii) bars the undersigned from
                                            being associated with any entity or from participating in the offering of any penny stock;
                                            and

 

		(s)	He,
                                            she or it has never been suspended or expelled from membership in, or suspended or barred
                                            from association with a member of, a securities self-regulatory organization (e.g., a registered
                                            national securities exchange or a registered national or affiliated securities association)
                                            for any act or omission to act constituting conduct inconsistent with just and equitable
                                            principles of trade.

 

11. [The
undersigned has full right and power, without violating any agreement by which he, she or it is bound, to enter into this letter agreement
and to serve as a Director and/or officer of the Company.]7

 

12. The
undersigned hereby waives his, her or its right to exercise redemption rights with respect to any Ordinary Shares owned or to be owned
by the undersigned, directly or indirectly (or to sell such shares to the Company in a tender offer), whether purchased by the undersigned
prior to the IPO, in the IPO or in the aftermarket, and agrees that he, she or it will not seek redemption with respect to or otherwise
sell, such shares in connection with any vote to approve a Business Combination with respect thereto, a vote to amend the provisions
of the Company’s Amended and Restated Memorandum and Articles of Association, or a tender offer by the Company prior to a Business
Combination.

 

13. The
undersigned hereby agrees to not propose, or vote in favor of, an amendment to the Company’s Amended and Restated Memorandum and
Articles of Association with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business
Combination unless the Company offers holders of IPO Shares the right to receive their pro rata portion of the funds then held in the
Trust Fund.

 

 

 

 

 

		7	NTD: Only remove for Bombax Capital Partners Limited and Be Expert Limited.

 

    5

     

    

 

14. In
connection with Section 5-1401 of the General Obligations Law of the State of New York, this letter agreement shall be governed by, and
construed in accordance with, the laws of the State of New York without regard to principles of conflicts of law that would result in
the application of the substantive law of another jurisdiction. The parties hereto agree that any action, proceeding or claim arising
out of or relating in any way to this letter agreement shall be resolved through final and binding arbitration in accordance with the
International Arbitration Rules of the American Arbitration Association (“AAA”). The arbitration shall be brought
before the AAA International Center for Dispute Resolution’s offices in New York City, New York, will be conducted in English and
will be decided by a panel of three arbitrators selected from the AAA Commercial Disputes Panel and that the arbitrator panel’s
decision shall be final and enforceable by any court having jurisdiction over the party from whom enforcement is sought. The cost of
such arbitrators and arbitration services, together with the prevailing party’s legal fees and expenses, shall be borne by the
non-prevailing party or as otherwise directed by the arbitrators.

 

15. As
used herein, (i) a “Business Combination” shall mean a merger, share exchange, asset acquisition, contractual
arrangement, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities;
(ii) “Insiders” shall mean all officers, directors and shareholders of the Company immediately prior to the
IPO; (iii) “Insider Shares” shall mean all of the Ordinary Shares of the Company acquired by an Insider prior
to the IPO and any Ordinary Shares underlying the Private Placement Warrants; (iv) “IPO Shares” shall mean
the Ordinary Shares issued in the Company’s IPO; (v) [“Private Placement Warrants” shall mean (x) the
Warrants purchased in the private placement taking place simultaneously with the consummation of the Company’s IPO and (y) the
additional Warrants that may be purchased in connection with the exercise of the over-allotment option by the underwriters in the IPO
as described in the Registration Statement;]8 (vi) “Registration Statement” means the registration
statement on Form S-1 filed by the Company with respect to the IPO; and (vii) “Trust Fund” shall mean the trust
fund into which a portion of the net proceeds of the Company’s IPO will be deposited.

 

16. Any
notice, consent or request to be given in connection with any of the terms or provisions of this letter agreement shall be in writing
and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery,
by electronic mail or by facsimile transmission.

 

 

 

 

 

		8	NTD:
Only include for Bombax Capital Partners Limited and Be Expert Limited.

 

    6

     

    

 

If
to the Representative:

 

JonesTrading
Institutional Services LLC

757 3rd Avenue, 23rd floor

New
York, NY 10017

Attn: Burke Cook

E-mail:
Burke@jonestrading.com

 

with
a copy (which copy shall not constitute notice) to:

 

King
& Spalding LLP

1185
Avenue of the Americas, 34th Floor

New
York, NY 10036

Attn:
Adam Hankiss, Esq. and Kevin E. Manz, Esq.

E-mail:
ahankiss@kslaw.com and kmanz@kslaw.com

 

If
to the Company:

 

Bombax Healthcare Acquisition Corporation

221 Henderson Road

#01-05 Henderson Road

Attn: Gary Chan, Chief Executive Officer

Email: gary.chan@cfocentre.com.hk

 

with
a copy (which copy shall not constitute notice) to:

Loeb
& Loeb LLP

345 Park Avenue

New York, NY 10154

Attn: Lawrence Venick, Esq.

Email: lvenick@loeb.com

 

17. No
party hereto may assign either this letter agreement or any of its rights, interests, or obligations hereunder without the prior written
consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate
to transfer or assign any interest or title to the purported assignee. This letter agreement shall be binding on the parties hereto and
any successors and assigns thereof.

 

18. This
Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and
supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they
relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended,
modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed
by all parties hereto.

 

19. The
undersigned acknowledges and understands that the Underwriters and the Company will rely upon the agreements, representations and warranties
set forth herein in proceeding with the IPO. Nothing contained herein shall be deemed to render the Underwriters a representative of,
or a fiduciary with respect to, the Company, its shareholders or any creditor or vendor of the Company with respect to the subject matter
hereof.

 

[Signature
pages follow]

 

    7

     

    

 

	 	Bombax Capital Partners Limited
	 	 	 
	 	By:	 
	 	Name: 	Tak Cheung Yam
	 	Title:	Director
	 	 	 
	 	Be Expert Limited
	 	 	 
	 	By:	 
	 	Name: 	 
	 	Title:	 
	 	 	 
	 	 	Gary Chan

	 	 	 
	 	 	 
	 	 	Kelvin Sze
	 	 	 
	 	 	 
	 	 	Dr. Hoon K. Lee
	 	 	 
	 	 	 
	 	 	Louis S. Villalba
	 	 	 
	 	 	 
	 	 	Ka Yin Norma Chu

 

 

8Exhibit 10.2

 

INVESTMENT MANAGEMENT TRUST AGREEMENT

 

This Agreement is made as of [_______], 2022 by and between Bombax
Healthcare Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”).

 

WHEREAS, the Company’s registration statement on Form S-1, No.
333-260274 (“Registration Statement”) for its initial public offering of securities (“IPO”) has been declared
effective as of the date hereof (“Effective Date”) by the Securities and Exchange Commission (capitalized terms used herein
and not otherwise defined shall have the meanings set forth in the Registration Statement); and

 

WHEREAS JonesTrading LLC (“JonesTrading”)
is acting as the underwriter in the IPO; and

 

WHEREAS, if the Company does
not consummate an initial business combination (“Business Combination”) within the initial 12-month period following the closing
of the IPO, the Company’s insiders may extend such period by four three-months periods, up to a maximum of 24 months in the aggregate,
by depositing $250,000 (or $287,500 if the Underwriters’ over-allotment option is exercised in full, or in any case, $0.05 per public
share) into the Trust Account (as defined below) no later than the 12-month anniversary of the IPO (or the 15-month, 18-month or 24-month
anniversary of the IPO, as applicable) (each, an “Applicable Deadline”) for each three-month extension (each, an “Extension”),
in exchange for which they will receive promissory notes, provided that if the Company has executed a letter of intent, agreement in principle
or definitive agreement for its Business Combination within 12 months from the closing of this offering but have not completed its Business
Combination within such 12-month period, it may choose to extend the period of time to consummate a Business Combination by an additional
three months at no cost to the insiders. ; and

 

WHEREAS, as described in the Registration Statement, and in accordance
with the Company’s Amended and Restated Memorandum and Articles of Association, $51,000,000 of the gross proceeds of the IPO and
the sale of the private placement warrants taking place simultaneously therewith ($58,650,000 if the over-allotment option is exercised
in full), will be delivered to the Trustee to be deposited and held in the Trust Account for the benefit of the Company and the holders
of the Company’s ordinary shares, par value $0.0001 per share, issued in the IPO as hereinafter provided (the proceeds to be delivered
to the Trustee will be referred to herein as the “Property”; the shareholders for whose benefit the Trustee shall hold the
Property will be referred to as the “Public Shareholders,” and the Public Shareholders and the Company will be referred to
together as the “Beneficiaries”); and

 

WHEREAS, the Company and the
Trustee desire to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.

 

IT IS AGREED:

 

1.
Agreements and Covenants of Trustee. The Trustee hereby agrees and covenants to:

 

(a)
Hold the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in a segregated trust account (“Trust
Account”) established by the Trustee at a United States-based trust account, maintained by Trustee, and at a brokerage institution
selected by the Trustee that is reasonably satisfactory to the Company;

 

(b)
Manage, supervise and administer the Trust Account subject to the terms and conditions set forth herein;

 

(c)
In a timely manner, upon the instruction of the Company, invest and reinvest the Property (i) in United States government treasury
bills, notes or bonds having a maturity of 180 days or less and/or (ii) in money market funds meeting certain conditions under Rule 2a-7
promulgated under the Investment Company Act of 1940, as amended, and that invest solely in U.S. treasuries, as determined by the Company;

 

    

     

    

 

(d)
 Collect and receive, when due, all principal and income arising from the Property, which shall become part of the “Property,”
as such term is used herein;

 

(e)
Notify the Company and JonesTrading of all communications received by it with respect to any Property requiring action by the Company;

 

(f)  
Supply any necessary information or documents as may be requested by the Company in connection with the Company’s preparation
of its tax returns;

 

(g)
Participate in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and when
instructed by the Company to do so;

 

(h)
Render to the Company monthly written statements of the activities of and amounts in the Trust Account reflecting all receipts
and disbursements of the Trust Account; and

 

(i) Commence liquidation of the Trust Account only after and promptly after
receipt of, and only in accordance with, the terms of a letter (“Termination Letter”), in a form substantially similar to
that attached hereto as either Exhibit A or Exhibit B, signed on behalf of the Company by its President, Chief Executive
Officer or Chairman of the Board and Secretary or Assistant Secretary and, in the case of a Termination Letter in a form substantially
similar to that attached hereto as Exhibit A, acknowledged and agreed to by JonesTrading, and complete the liquidation of the Trust
Account and distribute the Property in the Trust Account only as directed in the Termination Letter and the other documents referred to
therein; provided, however, that in the event that a Termination Letter has not been received by the Trustee by the 12-month anniversary
of the closing of the IPO (“Closing”) or, in the event that the Company extended the time to complete the Business Combination
for up to 24 months from the closing of the IPO but has not completed the Business Combination within the applicable monthly anniversary
of the Closing (“Last Date”), the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination
Letter attached as Exhibit B hereto and distributed to the Public Shareholders as of the Last Date.

 

(j) Upon receipt of an extension
letter (“Extension Letter”) substantially similar to Exhibit D hereto at least five business days prior to the Applicable
Deadline, signed on behalf of the Company by an executive officer, and receipt of the dollar amount specified in the Extension Letter
on or prior to the Applicable Deadline, to follow the instructions set forth in the Extension Letter.

 

(k)
Not disburse any amounts from the Trust Account in connection with
a Business Combination in the event that the amount per share to be received by the redeeming Public Shareholders is less than $10.20
per share (plus the amount per share deposited in the Trust Account pursuant to any Extension Letter).

 

(l)
In connection with a Business Combination, before making disbursements to the Depository Trust Company, the Company or any other
person, disburse the per share amount to redeeming Public Shareholders (other than shares tendered through the Depository Trust Company)
that have tendered their shares directly to the Trustee.

 

(m)
Promptly acknowledge and comply with any irrevocable instruction letter
delivered in the form of Exhibit E delivered by the Company in connection with the disbursement of funds to a Public Shareholder.

 

(n)
Promptly acknowledge, in writing to any redeeming Public Shareholder
and the Company, any irrevocable instruction letter in the form of Exhibit F delivered by such redeeming Public Shareholder after
the announcement by the Company of a proposed Business Combination and promptly comply with any irrevocable written instruction letter
in the form of Exhibit F delivered by such Public Shareholder in connection with the disbursement of funds to such Public Shareholder
if the Company has not notified the Trustee in writing during the Objection Period that such irrevocable written instruction letter is
a Non-Compliant Instruction Letter (as defined below).

 

    2

     

    

 

2.
Limited Distributions of Income from Trust Account.

 

(a)
Upon written request from the Company, which may be given from time
to time in a form substantially similar to that attached hereto as Exhibit C, the Trustee shall distribute to the Company the amount
of interest income earned on the Trust Account requested by the Company to cover any income or other tax obligation owed by the Company.

 

(b)
The limited distributions referred to in Section 2(a) above shall be made only from income collected on the Property. Except as
provided in Section 2(a), no other distributions from the Trust Account shall be permitted except in accordance with Section 1(i) hereof.

 

(c)
The Company shall provide JonesTrading with a copy of any Termination Letters and/or any other correspondence that it issues to
the Trustee with respect to any proposed withdrawal from the Trust Account promptly after such issuance.

 

3.
Agreements and Covenants of the Company. The Company hereby agrees and covenants to:

 

(a)
Give all instructions to the Trustee hereunder in writing, signed by the Company’s Chairman of the Board, Chief Executive
Officer, President or Chief Financial Officer. In addition, except with respect to its duties under paragraphs 1(i), 2(a) and 2(b) above,
the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or instruction which it
in good faith believes to be given by any one of the persons authorized above to give written instructions, provided that the Company
shall promptly confirm such instructions in writing;

 

(b)
Subject to the provisions of Sections 5 and 7(g) of this Agreement, hold the Trustee harmless and indemnify the Trustee from and
against, any and all expenses, including reasonable counsel fees and disbursements, or loss suffered by the Trustee in connection with
any claim, potential claim, action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any
claim or demand which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or
any income earned from investment of the Property, except for expenses and losses resulting from the Trustee’s gross negligence
or willful misconduct. Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action, suit
or proceeding, pursuant to which the Trustee intends to seek indemnification under this paragraph, it shall notify the Company in writing
of such claim (hereinafter referred to as the “Indemnified Claim”); provided, however, that the Trustee’s failure to
provide such notice shall not relieve the Company of its liability hereunder, except to the extent that it is materially prejudiced by
such failure. The Trustee shall have the right to conduct and manage the defense against such Indemnified Claim, provided, that the Trustee
shall obtain the consent of the Company with respect to the selection of counsel, which consent shall not be unreasonably withheld. The
Trustee may not agree to settle any Indemnified Claim without the prior written consent of the Company,
which consent shall not be unreasonably withheld or delayed. The Company may participate in such action with its own counsel;

 

    3

     

    

 

(c)
Pay the Trustee an initial acceptance fee, an annual fee and a transaction processing fee for each disbursement made pursuant to
Sections 2(a) and 2(b) as set forth on Schedule A hereto, which fees shall be subject to modification by the parties from time to time.
It is expressly understood that the Property shall not be used to pay such fees and further agreed that any fees owed to the Trustee shall
be deducted by the Trustee from the disbursements made to the Company pursuant to Sections 1(i) solely in connection with the consummation
of a Business Combination, or pursuant to Section 2(b). The Company shall pay the Trustee the initial acceptance fee and first year’s
fee at the consummation of the IPO and thereafter on the anniversary of the Effective Date;

 

(d)
In connection with any vote of the Company’s shareholders regarding a Business Combination, provide to the Trustee an affidavit
or certificate of a firm regularly engaged in the business of soliciting proxies and/or tabulating shareholder votes verifying the vote
of the Company’s shareholders regarding such Business Combination; and

 

(e)
In the event that the Company directs the Trustee to commence liquidation of the Trust Account pursuant to Section 1(i), the Company
agrees that it will not direct the Trustee to make any payments that are not specifically authorized by this Agreement.

 

(f)
Upon receiving the written request of a Public Shareholder to do so
at any time after the date hereof, provide such Public Shareholder with a copy of any instruction provided to the Trustee pursuant to
Section 1(i) along with any Notification (as defined in Exhibit A), Instruction Letter (as defined in Exhibit A), applicable
flow of funds memorandum (or similar document), or any other notice delivered to the Trustee by the Company regarding the disbursement
of Property from the Trust Account resulting in the Property left in the Trust Account being less than $51,000,000 (or $58,650,000 if
the Underwriters’ over-allotment option is exercised in full) plus any amount eventually deposited on account of any Extension,
which, in each case, shall specify to whom the Property shall be disbursed (such written notice, a “Disbursement Notice” and
the date such Public Shareholder receives a Disbursement Notice, a “Disbursement Notice Date”). Each Disbursement Notice shall
be delivered to such Public Shareholder at least two business days prior to the disbursement of any Property pursuant to Section 1(i)
and no Property shall be disbursed from the Trust Account prior to the date that is two business days from the applicable Disbursement
Notice Date.

 

(g)
At the request of any Public Shareholder who has removed shares from
street name and holds such shares either in certificated or book-entry form and, except if such shares are held in book-entry form, delivered
such certificated shares to the Trustee for purposes of redemption in connection with a Business Combination, concurrently with the delivery
of such shares, solely if such shares are certificated. to the Trustee, send an irrevocable written instruction letter in the form of
Exhibit E to the Trustee directing the Trustee to disburse no less than $10.20 per share (plus the amount per share deposited in
the Trust Account pursuant to any Extension Letter) to such Public Shareholder.

 

(h)
Following receipt of a copy of an irrevocable written instruction letter
in the form of Exhibit F delivered by a Public Shareholder who has removed shares from street name and holds such shares either
in certificated or book-entry form and, except if such shares are held in book-entry form, delivered such certificated shares to the Trustee
for purposes of redemption in connection with a Business Combination to the Trustee, review such letter to confirm (i) such letter is
in the form of Exhibit F, (ii) a Business Combination has been announced on or prior to the date of such letter and (iii) the number
of ordinary shares set forth on such letter to be redeemed is not greater than the number of ordinary shares held by the applicable Public
Shareholder. Solely if the Company cannot confirm the requirements of clauses (i) through (iii) of this Section 3(h), but not for any
other reason, then within two days of the Company’s receipt of the applicable copy of the irrevocable written instruction letter
in the form of Exhibit F (such time period, the “Objection Period”), the Company will notify the applicable Public
Shareholder and the Trustee in writing that such irrevocable written instruction letter is a “Non-Compliant Instruction Letter”
and that the Trustee shall not comply with such letter.

 

    4

     

    

 

(i)
If applicable, the Company shall issue a press release at least three days prior to the Applicable Deadline announcing that, at
least five days prior to the Applicable Deadline, the Company received notice from the Company’s insiders that the insiders intend
to extend the Applicable Deadline;

 

(j)
Promptly following the Applicable Deadline, disclose whether or not the term the Company has to consummate a Business Combination
has been extended.

 

4.
Limitations of Liability. The Trustee shall have no responsibility or liability to:

 

(a)
Take any action with respect to the Property, other than as directed in paragraphs 1 and 2 hereof and the Trustee shall have no
liability to any party except for liability arising out of its own gross negligence or willful misconduct;

 

(b)
Institute any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding
of any kind with respect to, any of the Property unless and until it shall have received instructions from the Company given as provided
herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any expenses incident thereto;

 

(c)
Change the investment of any Property, other than in compliance with paragraph 1(c);

 

(d)
Refund any depreciation in principal of any Property;

 

(e)
Assume that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless
provided otherwise in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;

 

(f)  
The other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted,
in good faith and in the exercise of its own best judgment, except for its gross negligence or willful misconduct. The Trustee may rely
conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including counsel
chosen by the Trustee), statement, instrument, report or other paper or document (not only as to its due execution and the validity and
effectiveness of its provisions, but also as to the truth and acceptability
of any information therein contained) which is believed by the Trustee, in good faith, to be genuine and to be signed or presented by
the proper person or persons. The Trustee shall not be bound by any notice or demand, or any waiver, modification, termination or rescission
of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee signed by the proper party
or parties and, if the duties or rights of the Trustee are affected, unless it shall give its prior written consent thereto;

 

    5

     

    

 

(g)
Verify the correctness of the information set forth in the Registration Statement or to confirm or assure that any acquisition
made by the Company or any other action taken by it is as contemplated by the Registration Statement;

 

(h)
File local, state and/or federal tax returns or information returns with any taxing authority on behalf of the Trust Account and
payee statements with the Company documenting the taxes, if any, payable by the Company or the Trust Account, relating to the income earned
on the Property;

 

(i)
Pay any taxes on behalf of the Trust Account (it being expressly understood that the Property shall not be used to pay any such
taxes and that such taxes, if any, shall be paid by the Company from funds not held in the Trust Account or released to it under Section
2(a) hereof);

 

(j)
Imply obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this
agreement and that which is expressly set forth herein; and

 

(k)
Verify calculations, qualify or otherwise approve Company requests for distributions pursuant to Section 1(i), 2(a) or 2(b) above.

 

5.
Trust Account Waiver. The Trustee has no right of set-off or any right, title, interest or claim of any kind (“Claim”)
to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it
may have now or in the future. In the event the Trustee has any Claim against the Company under this Agreement, including, without limitation,
under Section 3(b) or Section 3(c) hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside the Trust
Account and not against the Property or any monies in the Trust Account.

 

6.
Termination. This Agreement shall terminate as follows:

 

(a)
If the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable
efforts to locate a successor trustee during which time the Trustee shall act in accordance with this Agreement. At such time that the
Company notifies the Trustee that a successor trustee has been appointed by the Company and has agreed to become subject to the terms
of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited
to the transfer of copies of the reports and statements relating to the Trust Account, whereupon this Agreement shall terminate; provided,
however, that, in the event that the Company does not locate a successor trustee within ninety days of receipt of the resignation notice
from the Trustee, the Trustee may submit an application to have the Property deposited
with any court in the State of New York or with the United States District Court for the Southern District of New York and upon such deposit,
the Trustee shall be immune from any liability whatsoever; or

 

    6

     

    

 

(b)
At such time that the Trustee has completed the liquidation of the Trust Account in accordance with the provisions of paragraph
1(i) hereof, and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate
except with respect to Paragraph 3(b).

 

7.
Miscellaneous.

 

(a)
The Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect
to funds transferred from the Trust Account. The Company and the Trustee will each restrict access to confidential information relating
to such security procedures to authorized persons. Each party must notify the other party immediately if it has reason to believe unauthorized
persons may have obtained access to such information, or of any change in its authorized personnel. In executing funds transfers, the
Trustee will rely upon all information supplied to it by the Company, including account names, account numbers and all other identifying
information relating to a beneficiary, beneficiary’s bank or intermediary bank. The Trustee shall not be liable for any loss, liability
or expense resulting from any error in the information or transmission of the wire.

 

(b)
This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving
effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. It may be
executed in several original or facsimile counterparts, each one of which shall constitute an original, and together shall constitute
but one instrument.

 

(c)
This Agreement contains the entire agreement and understanding of the
parties hereto with respect to the subject matter hereof. Except for Sections 1(i), 1(l), 1(m), 3(g), 3(h), 7(c) and 7(h) (which may only
be amended with the approval of the holders of at least 50% of the ordinary shares sold in the IPO, provided that all Public Shareholders
must be given the right to receive a pro-rata portion of the trust account (no less than $10.20 per share plus the amount per share deposited
in the Trust Account pursuant to any Extension Letter) in connection with any such amendment), this Agreement or any provision hereof
may only be changed, amended or modified by a writing signed by each of the parties hereto; provided, however, that no such change, amendment
or modification may be made without the prior written consent of JonesTrading. As to any claim, cross-claim or counterclaim in any way
relating to this Agreement, each party waives the right to trial by jury. The Trustee may require from Company counsel an opinion as to
the propriety of any proposed amendment.

 

(d)
The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, Borough
of Manhattan, for purposes of resolving any disputes hereunder.

 

    7

     

    

 

(e)
Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing
and shall be sent by express mail or similar private courier service, by certified
mail (return receipt requested), by hand delivery, by electronic mail or by facsimile transmission:

 

if to the Trustee, to:

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: Francis Wolf and Celeste Gonzalez

Email: fwolf@continentalstock.com

Email: cgonzalez@continentalstock.com

 

if to the Company, to:

 

Bombax Healthcare Acquisition Corporation

221 Henderson Road

#01-05 Henderson Road

Singapore 159557

Attn: Gary Chan , Chief Executive Officer

E-mail: gary.chan@cfocentre.com.hk

 

in either case with a copy (which
copy shall not constitute notice) to:

 

JonesTrading Institutional Services LLC

757 3rd Avenue, 23rd floor

New York, NY 10017

Attn: Burke Cook

E-mail: Burke@jonestrading.com

 

and

 

Loeb & Loeb LLP

345 Park Avenue

New York, New York 10154

Attn: Lawrence Venick, Esq.

E-mail: lvenick@loeb.com

 

and

 

King & Spalding LLP

1185 Avenue of the Americas, 34th Floor

New York, NY 10036

Attn: Adam Hankiss, Esq. and Kevin E. Manz, Esq.

E-mail: ahankiss@kslaw.com and kmanz@kslaw.com

 

(f)
This Agreement may not be assigned by the Trustee without the prior consent of the Company.

 

(g)
 Each of the Trustee and the Company hereby represents that it has the full right and power and has been duly authorized to enter
into this Agreement and to perform its respective obligations as contemplated hereunder.

 

(h)
Each of the Company and the Trustee hereby acknowledge that JonesTrading is a third party beneficiary of this Agreement.

 

[signature page follows]

 

    8

     

    

 

IN WITNESS WHEREOF, the parties have duly executed
this Investment Management Trust Agreement as of the date first written above.

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Trustee
	 	 	 
	 	By:	 
	 	 	Name:	 Francis Wolf
	 	 	Title:	Vice President
	 	 	 	 
	 	BOMBAX HEALTHCARE ACQUISITION CORPORATION
	 	 	 
	 	By:	 
	 	 	Name:	Gary Chan

	 	 	Title:	Chief Executive Officer

 

    

     

    

 

SCHEDULE A

 

	Fee Item	 	Time and method of payment	 	Amount
	Initial acceptance fee	 	Initial closing of IPO by wire transfer	 	$[_________] 
	 	 	 	 	 
	Annual fee	 	Initial closing of IPO by wire transfer; thereafter on the anniversary of the effective date of the IPO by wire transfer or check	 	$[_________]
	 	 	 	 	 
	Transaction processing fee for disbursements to Company under Section 2	 	Deduction by Trustee from accumulated income following disbursement made to Company under Section 2	 	$[_________]
	 	 	 	 	 
	Paying Agent services as required pursuant to section 1(i)	 	Billed to Company upon delivery of service pursuant to section 1(i)	 	Prevailing rates

 

    

     

    

 

EXHIBIT A

 

[Letterhead of Company]

 

[Insert date]

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: [________________]

 

		Re:	Trust Account No. [_____________] - Termination Letter

 

Gentlemen:

 

Pursuant to paragraph 1(i) of the Investment Management Trust Agreement
between Bombax Healthcare Acquisition Corporation (“Company”) and Continental Stock Transfer & Trust Company (“Trustee”),
dated as of [   ], 2022 (“Trust Agreement”), this is to advise you that the Company has entered into an agreement with [__________________]
(“Target Business”) to consummate a business combination with Target Business (“Business Combination”) on or about
[insert date]. The Company shall notify you at least 48 hours in advance of the actual date of the consummation of the Business
Combination (“Consummation Date”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth
in the Trust Agreement.

 

In accordance with the terms
of the Trust Agreement, we hereby authorize you to liquidate the Trust Account investments on [__________] and to transfer the proceeds
to the above-referenced account at a United States-based trust account to the effect that, on the Consummation Date, all of funds held
in the Trust Account will be immediately available for transfer to the account or accounts that the Company shall direct on the Consummation
Date. It is acknowledged and agreed that while the funds are on deposit in the trust account awaiting distribution, the Company will not
earn any interest or dividends.

 

On the Consummation Date (i) counsel for the Company shall deliver
to you written notification that the Business Combination has been consummated, and (ii) the Company shall deliver to you (a) [an affidavit]
[a certificate] of [__________________], which verifies the vote of the Company’s shareholders in connection with the Business Combination
if a vote is held and (b) joint written instructions from the Company and JonesTrading Institutional Services LLC with respect to the
transfer of the funds held in the Trust Account, which must provide for the disbursement of no less than $10.20 per share plus the amount
per share deposited in the Trust Account per Extension Letter to redeeming Public Shareholders (“Instruction Letter”). You
are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the counsel’s
letter and the Instruction Letter, in accordance with the terms of the Instruction Letter. In the event that certain deposits held in
the Trust Account may not be liquidated by the Consummation Date without penalty, you will notify the Company of the same and the Company
shall direct you as to whether such funds should remain in the Trust Account and distributed after the Consummation Date to the Company.
Upon the distribution of all the funds in the Trust Account pursuant to the terms hereof, the Trust Agreement shall be terminated.

 

    A-1

     

    

 

In the event that the Business
Combination is not consummated on the Consummation Date described in the notice thereof and we have not notified you on or before the
original Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the
funds held in the Trust Account shall be reinvested as provided in the Trust Agreement on the business day immediately following the Consummation
Date as set forth in the notice.

 

	 	Very truly yours,
	 	 
	 	BOMBAX HEALTHCARE ACQUISITION CORPORATION
	 	 
	 	By:	 
	 	Name:	 Gary Chan

	 	Title:	 Chief Executive Officer
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	Secretary/Assistant Secretary

 

	Acknowledged and Agreed:	 
	 	 
	JonesTrading Institutional Services LLC	 
	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 

 

    A-2

     

    

 

EXHIBIT B

 

[Letterhead of Company]

 

[Insert date]

 

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: [________________]

 

		Re:	Trust Account No. [______________] - Termination Letter

 

Gentlemen:

 

Pursuant to paragraph 1(i) of the Investment Management Trust Agreement
between Bombax Healthcare Acquisition Corporation (“Company”) and Continental Stock Transfer & Trust Company (“Trustee”),
dated as of [   ], 2022 (“Trust Agreement”), this is to advise you that the Company has been unable to effect a Business Combination
with a Target Company within the time frame specified in the Company’s Amended and Restated Memorandum and Articles of Association,
as described in the Company’s prospectus relating to its IPO. Capitalized terms used herein and not otherwise defined shall have
the meanings set forth in the Trust Agreement.

 

In accordance with the terms
of the Trust Agreement, we hereby authorize you to liquidate all the Trust Account investments on [______________] and to transfer the
total proceeds to the Trust Operating Account at a United States-based trust account to await distribution to the Public Shareholders.
The Company has selected [____________, 20__] as the effective date for the purpose of determining when the Public Shareholders will be
entitled to receive their share of the liquidation proceeds. It is acknowledged that no interest will be earned by the Company on the
liquidation proceeds while on deposit in the Trust Checking Account. You agree to be the Paying Agent of record and in your separate capacity
as Paying Agent, to distribute said funds directly to the Public Shareholders in accordance with the terms of the Trust Agreement and
the Amended and Restated Memorandum and Articles of Association of the Company. Upon the distribution of all the funds in the Trust Account,
your obligations under the Trust Agreement shall be terminated.

 

	 	Very truly yours,
	 	 
	 	BOMBAX HEALTHCARE ACQUISITION CORPORATION
	 	 
	 	By:	 
	 	Name:	Gary Chan

	 	Title:	Chief Executive Officer

 

	 	By:	 
	 	Name:	 
	 	Title: 	Secretary/Assistant Secretary

 

		cc:	JonesTrading Institutional Services LLC

 

    B-1

     

    

 

EXHIBIT C

 

[Letterhead of Company]

 

[Insert date]

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: [________________]

 

		Re:	Trust Account No. [___________]

 

Gentlemen:

 

Pursuant to paragraph 2(a) of the Investment Management Trust Agreement
between Bombax Healthcare Acquisition Corporation (“Company”) and Continental Stock Transfer & Trust Company (“Trustee”),
dated as of [    ], 2022 (“Trust Agreement”), the Company hereby requests that you deliver to the Company [$_______] of the interest
income earned on the Property as of the date hereof. The Company needs such funds to pay for its tax obligations. In accordance with the
terms of the Trust Agreement, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt
of this letter to the Company’s operating account at:

 

[WIRE INSTRUCTION INFORMATION]

 

	 	BOMBAX HEALTHCARE ACQUISITION CORPORATION
	 	 
	 	By:	 
	 	Name:	 Gary Chan

	 	Title:	Chief Executive Officer

 

		cc:	JonesTrading Institutional Services LLC

 

    C-1

     

    

 

EXHIBIT D

[Letterhead of Company]

[Insert date]

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: [________________]

 

		Re:	Trust Account - Extension Letter

 

Gentlemen:

 

Pursuant to Section 1(j) of the Investment Management
Trust Agreement Bombax Healthcare Acquisition Corporation (“Company”) and Continental Stock Transfer & Trust Company,
dated as of [*], 2022 (“Trust Agreement”), this is to advise you that the Company is extending the time available in order
to consummate a Business Combination with the Target Businesses for an additional three (3) months, from _______ to _________ (the “Extension”).

 

This Extension Letter shall serve as the notice
required with respect to Extension prior to the Applicable Deadline. Capitalized words used herein and not otherwise defined shall have
the meanings ascribed to them in the Trust Agreement.

 

In accordance with the terms of the Trust Agreement,
we hereby authorize you to deposit [$250,000] [(or $287,500 if the underwriters’ over-allotment option was exercised in full, or
in any case, $0.05 per public share)], which will be wired to you, into the Trust Account investments upon receipt.

 

This is the ____ of up to [four] Extension Letters.

 

	 	Very truly yours,
	 	 
	 	BOMBAX HEALTHCARE ACQUISITION CORPORATION
	 	 	 
	 	By:	                   
	 	Name: 	 
	 	Title:	 

 

		cc:	JonesTrading Institutional Services LLC

 

    D-1

     

    

 

EXHIBIT E

 

[Letterhead of Company]

 

[Insert date]

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: [________________]

 

		Re:	Trust Account No. [______________] - Irrevocable Instruction in Connection with Business Combination

 

Gentlemen:

 

Pursuant to paragraphs 1(m) and 3(g) of the Investment Management Trust
Agreement between Bombax Healthcare Acquisition Corporation (“Company”) and Continental Stock Transfer & Trust Company
(“Trustee”), dated as of [    ], 2022 (“Trust Agreement”), this constitutes our irrevocable instruction to you to
(i) in conjunction with the Business Combination (as defined in the Trust Agreement), disburse a per share amount of $______, for a total
disbursement of $__________________which is not less than $10.20 (plus the amount per share deposited in the Trust Account per any Extension
Letter) to ________________ (the “Shareholder”) for the _____________________ ordinary shares of the Company delivered to
you prior to or concurrently herewith for redemption in connection with the Business Combination, and (ii) deliver to the Shareholder
the amounts specified in clause (i) prior to delivering and amounts to the Depository Trust Company, the Company, or any person from whom
you have not received an irrevocable instruction substantially similar to this one. The Shareholder wire instructions are attached. A
share advice or DWAC instruction from our broker is also attached.

 

The Company shall indemnify you and your officers,
directors, principals, partners, agents and representatives, and hold each of them harmless from and against any and all loss, liability,
damage, claim or expense (including the reasonable fees and disbursements of its attorneys) incurred by or asserted against you or any
of them arising out of or in connection with the instructions set forth herein, the performance of your duties hereunder and otherwise
in respect hereof, including the costs and expenses of defending yourself or themselves against any claim or liability hereunder, except
that the Company shall not be liable hereunder as to matters in respect of which it is determined that you have acted with gross negligence
or in bad faith. You shall have no liability to the Company in respect to any action taken or any failure to act in respect of this if
such action was taken or omitted to be taken in good faith, and you shall be entitled to rely in this regard on the advice of counsel.

 

The Board of Directors of the Company has approved
the foregoing irrevocable instructions and does hereby extend the Company’s irrevocable agreement to indemnify your firm for all
loss, liability or expense in carrying out the authority and direction herein contained on the terms herein set forth.

 

The Shareholder is intended to be and is a third
party beneficiary of this letter and the irrevocable instructions set forth herein, and no amendment or modification to the instructions
set forth herein may be made without the prior written consent of the Shareholder.

 

By signing below, the person executing this letter
certifies that they are duly authorized to execute this letter on behalf of the Company and to bind the Company to all of the terms and
conditions contained herein.

 

[remainder of page intentionally left blank]

 

    E-1

     

    

 

	 	Very truly yours,
	 	 
	 	BOMBAX HEALTHCARE ACQUISITION CORPORATION
	 	 
	 	By:	 
	 	Name:	 Gary Chan

	 	Title: 	Chief Executive Officer

 

Acknowledged and Agreed:

CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Trustee

 

	 	 
	Name:	 
	Title:	 

 

		Cc:	[SHAREHOLDER].

 

Attachments:

Shareholder Wire Instructions

Share advice or instruction

 

    E-2

     

    

 

EXHIBIT F

 

[Letterhead of Company]

 

[Insert date]

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: [________________]

 

		Re:	Trust Account No. [______________] - Irrevocable Instruction in Connection with Business Combination

 

Gentlemen:

 

Pursuant to paragraphs 1(n) and 3(h) of the Investment Management Trust
Agreement between Bombax Healthcare Acquisition Corporation (“Company”) and Continental Stock Transfer & Trust Company
(“Trustee”), dated as of [    ], 2022 (“Trust Agreement”), this constitutes our irrevocable instruction to you to
(i) in conjunction with the Business Combination (as defined in the Trust Agreement), disburse a per share amount of $______, for a total
disbursement of $_________________which is not less than $10.20 (plus the amount per share deposited in the Trust Account per any Extension
Letter) per share to ________________ (the “Shareholder”) for the _____________________ ordinary shares of the Company delivered
to you prior to or concurrently herewith for redemption in connection with the Business Combination, and (ii) deliver to the Shareholder
the amounts specified in clause (i) prior to delivering and amounts to the Depository Trust Company, the Company, or any person from whom
you have not received an irrevocable instruction substantially similar to this one. Our wire instructions are attached. We understand
that a servicing fee of $250.00 will deducted from our payment. A share advice or DWAC instruction from our broker is attached.

 

The Company shall indemnify you and your officers,
directors, principals, partners, agents and representatives, and hold each of them harmless from and against any and all loss, liability,
damage, claim or expense (including the reasonable fees and disbursements of its attorneys) incurred by or asserted against you or any
of them arising out of or in connection with the instructions set forth herein, the performance of your duties hereunder and otherwise
in respect hereof, including the costs and expenses of defending yourself or themselves against any claim or liability hereunder, except
that the Company shall not be liable hereunder as to matters in respect of which it is determined that you have acted with gross negligence
or in bad faith. You shall have no liability to the Company in respect to any action taken or any failure to act in respect of this if
such action was taken or omitted to be taken in good faith, and you shall be entitled to rely in this regard on the advice of counsel.

 

The Board of Directors of the Company does hereby
extend the Company’s irrevocable agreement to indemnify your firm for all loss, liability or expense in carrying out the authority
and direction herein contained on the terms herein set forth.

 

No amendment or modification to the instructions
set forth herein may be made without the prior written consent of the Shareholder.

 

By signing below, the person executing this letter
certifies that they are duly authorized to execute this letter on behalf of the Shareholder and to bind the Shareholder to all of the
terms and conditions contained herein.

 

[remainder of page intentionally left blank]

 

    F-1

     

    

 

	 	Very truly yours,
	 	 
	 	[SHAREHOLDER]
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

Acknowledged and Agreed:

CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Trustee

 

	 	 
	Name:	 
	Title:	 

 

		Cc:	Bombax Healthcare Acquisition Corporation

221 Henderson Road

#01-05 Henderson Road

Singapore 159557

			Attn: Gary Chan, Chief Executive Officer

 

Attachments:

Shareholder Wire Instructions

Share advice or instruction

 

 

F-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]